4D Molecular Therapeutics (FDMT) Receivables - Other (2019 - 2022)
4D Molecular Therapeutics (FDMT) posted quarterly Receivables - Other of $700000.0 for Q4 2022, little changed year-over-year from $700000.0 in Q4 2021, and little changed quarter-over-quarter from $700000.0 in Q4 2021.
4D Molecular Therapeutics (FDMT) Receivables - Other (2019 - 2022) Analysis & Trends
4D Molecular Therapeutics (FDMT) has reported Receivables - Other for 3 consecutive years, with $700000.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Receivables - Other changed 0.0% year-over-year to $700000.0; the TTM figure through Dec 2022 stood at $700000.0 (changed 0.0% YoY), while the FY2022 annual figure was $700000.0, changed 0.0% from the prior year.
- Receivables - Other steadied at $700000.0 in Q4 2022 per FDMT's latest filing, from $700000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $700000.0 in Q4 2021 and bottomed at $149000.0 in Q4 2019.
- Historically, Receivables - Other has averaged $527500.0 across 3 years, with a median of $630500.0 in 2021.
- On a YoY basis, Receivables - Other climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
- 4D Molecular Therapeutics' Receivables - Other stood at $149000.0 in 2019, then jumped by 369.8% to $700000.0 in 2021, then changed by 0.0% to $700000.0 in 2022.
- Business Quant data shows FDMT's Receivables - Other at $700000.0 in Q4 2022, $700000.0 in Q4 2021, and $561000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | 4D Molecular Therapeutics | 856.62 Mn | 495.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 700,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Dec 31, 2021 | 700,000.00 |
| Dec 31, 2021 | 700,000.00 |
| Mar 31, 2021 | 561,000.00 |
| Mar 31, 2021 | 561,000.00 |
| Dec 31, 2019 | 149,000.00 |
| Dec 31, 2019 | 149,000.00 |